Skip to content
OpenCapital
Get started

MAZE MAZE Price / sales

Price / sales at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
9.3×-1.9×
Septerna, Inc. logo
Septerna, Inc.SEPN
14.9×-248×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
60×+58.2×
Zymeworks logo
ZymeworksZYME
22.9×+14.0×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
22.9×+2.1×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
166.6×+109×

Other financials

Income statement

See full
Revenue$20.0M—
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B—
Enterprise value$1.34B—

Profitability

See full
Operating margin-71.5%—
Net margin-65.4%—
FCF margin-65.1%—

Returns & leverage

See full
Return on equity-38.7%—
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×